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Partition coefﬁcientAntimicrobial peptides are an important component of innate immunity and have generated considerable
interest as a new potential class of natural antibiotics. The biological activity of antimicrobial peptides
is strongly inﬂuenced by peptide–membrane interactions. Human Neutrophil Peptide 1 (HNP-1) is a 30
aminoacid peptide, belonging to the class of α-defensins. Many biophysical studies have been performed
on this peptide to deﬁne its mechanism of action. Combining spectroscopic and thermodynamic analysis,
insights on the interaction of the α-defensin with POPE:POPG:CL negative charged bilayers are given. The
binding states of the peptide below and above the threshold concentration have been analyzed showing
that the interaction with lipid bilayers is dependent by peptide concentration. These novel results that indi-
cate how afﬁnity and biological activities of natural antibiotics are depending by their concentration, might
open new way of investigation of the antimicrobial mode of action.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
A wide variety of organisms produces antimicrobial peptides
(AMPs) as part of their ﬁrst line of defence [1]. AMPs are typically rel-
atively short (12 to 100 amino acids), positively charged (net charge
ranging from+2 to +9, with+4 to +6 being the most common) and
contain about ~50–70%of hydrophobic amino acids [1–5]. AMPs display
a broad spectrum of antimicrobial activity against both Gram-positive
and Gram-negative bacteria, fungi, yeast and enveloped viruses [6].
It is believed that the mechanism of antimicrobial action is related
to the permeabilization of the microbial cell membrane [6,7]. In this
context the lipid composition is a key factor to better understand
the peptide:lipid interaction in model membranes [5–7]. Several
models have been proposed to describe the molecular events in-
volved in the AMP-mediated membrane disruption, including the for-
mation of barrel-stave peptide channels, induction of peptide–lipidhuman neutrophil peptide 1;
ichroism; POPG, 1-palmitoyl-
almitoyl-2-oleoyl-sn-glycerol-
yl cardiolipin ammonium salt;
, Large Unilamellar Vesicle;
, 1,2-dimyristoyl-sn-glycero-
hatidylglycerol
, University of Siena, Via A. de
fax: +39 0577 234239.
l rights reserved.toroidal pores and a detergent-like mechanism [2–8]. The threshold
concentration of AMPs is an important factor to understand their
mechanism of action. Generally, the interaction between peptides
and lipids takes place in two steps: deposition on the membrane sur-
face and insertion into the bilayer. At exceeding threshold concentra-
tions, all peptides are able to destabilize the phospholipid bilayer and
cause membrane disruption [7,9–13]. For this reason, it is likely that
some results for putative AMPs permeabilizing vesicles are essentially
artefacts that arise from extremely high peptide:lipid ratios used. In
general, any membrane-interacting molecule can disrupt membranes
at very high concentrations.
Human Neutrophil Peptide 1 (HNP-1) is a peptide belonging to
the class of α-defensins, which are produced in azurophil granules of
neutrophils [14]. This 30 amino acid peptide is present as a dimer in so-
lution. Each monomer unit is composed of three anti-parallel β-sheet
and a β-hairpin. The peptide structure is strongly stabilized by three
cysteine disulﬁde bridges (C2–C30, C4–C19, C9–C29) interconnecting
each β-sheet and a salt bridge between Arg-5 and Glu-13 [15]. HNP-1
has a positive net charge equal to +3, conferred by four cationic argi-
nine residues and the single anionic glutamic acid residue [16–18].
The generalmechanism for its antimicrobial action relies on the perme-
abilization of the microbial cell membrane [19,20] and the importance
of Arg and Trp residues of HNP-1 for this membrane interaction is
now clear [21–24]. A “dimer pore”model for HNP-1 has been suggested
on the basis of a crystal structure study [25], while a multimeric pore
model was proposed on the basis of vesicle leakage and dextran perme-
ability experiments [26].
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and Fluorescence) and thermodynamic techniques have been used
to analyze the binding states of the HNP-1 peptide with POPE:POPG:
CL liposomes as it accumulates on the bilayer surface. The peptide:
lipid 1:20 molar ratio has been determined as the threshold concen-
tration at which the peptide penetrates into the bilayer. When the
α-defensin:lipidmolar ratio is above or below the threshold concentra-
tion, the peptide tends to accumulate on the membrane surface with
a different mechanism of action.
2. Material and methods
The HNP-1 peptide [ACYCRIPACIAGERRYGTCIYQGRLWAFCC] was
obtained fromBachemPeptide (Bubendorf, CH) andusedwithout further
puriﬁcation. The phospholipids for vesicle preparation, 1-palmitoyl-
2oleoyl-sn-glycerol-3-phosphoglycerol (POPG), 1-palmitoyl-2oleoyl-
sn-glycerol-3-phosphoethanolamine(POPE), 1,1′,2,2′-tetramyristoyl
cardiolipin ammonium salt (CL), and spin-labeled phosphatidylcholine
(1-acyl-2-[n-(4,4dimethyloxazolidinyl-N-oxyl)]stearoyl-sn-glycero-3-
phosphocholine, n-PCSL, with n=5, 7, 12) were obtained from Avanti
Polar Lipids (Alabaster, AL). The buffer solution (pH 6.8) used in the ex-
periments contains 50 mM of 3-(N-morpholino) propanesulfonic acid
(MOPS) (Sigma Aldrich). MOPS is a buffer largely used for biological
sample preparation due to its low salt content [27].
2.1. Liposome preparation
Liposomes were prepared mixing 14 mM POPE, 12.9 mM POPG
and 6.6 mM CL (POPE:POPG:CL 70:25:5 molar ratio), in agreement
with the composition of Gram-negative bacterial inner membrane
lipids [13,28].
Lipids at the desired molar ratio were dried down from chloroform
stock solutions under a stream of nitrogen gas and then dried under
vacuum for 1 h. The resulting lipid ﬁlm was hydrated by adding
50 mM MOPS at pH 6.8 to reach a ﬁnal concentration of about
50 mM phospholipids. Large unilamellar vesicles (LUVs) were pre-
pared by freeze-thawing this lipid suspension ﬁve times followed by
extrusion through 200 nm polycarbonate membrane ﬁlters using a
miniextruder syringe device (Avanti Polar Lipids). Final concentration
of LUVs was determined using the Stewart phospholipids assay [29].
LUVs containing 1 mol of 5, 7, or 12-PCSL were prepared as described
above. Different peptide:lipid molar ratios were prepared (1:5, 1:10,
1:15, 1:20, 1:30, 1:50, 1:100, 1:250 and 1:350) where the HNP-1 pep-
tide was incubated with LUVs in 50 mMMOPS buffer at pH 6.8 for 1 h.
2.2. Circular dichroism spectroscopy
CD experiments were performed at room temperature on a Jasco
CD-J-815 spectropolarimeter using a quartz cuvette with a path length
of 1 mm. Peptide was suspended at 0.02 mM concentration in 50 mM
MOPS at pH 6.8with a variable concentration of LUVs ranging from 0.1
to 7 mM. CD spectra were recorded from 190 to 250 nm and
accumulated ten times to improve the signal-to-noise ratio. Baselines
of either solvent or vesicular suspension without peptide were
subtracted from each respective sample to calculate the peptide con-
tribution [30].
2.3. Electron Paramagnetic Resonance spectroscopy
EPR spectra were recorded on a Bruker E500 ELEXSYS X-Band
spectrometer equipped with a super-high-Q cavity. Samples prepared
for EPR measurements contained 0.4 mM of n-PCSL LUVs and a vari-
able concentration of peptide ranging from 0.02 to 0.08 mM. Spectra
were recorded using the following instrumental settings: 120 G sweep
width; 100 kHz modulation frequency; 1.0 G modulation amplitude;
40 ms time constant; 20 mW microwave power. Several scans,generally 15, were made to improve the signal-to-noise ratio. Values
of the outer hyperﬁne splitting, 2Amax, were determined by measuring
the difference between the low-ﬁeld maximum and minimum. Mea-
surements were performed in triplicate and the reproducibility of
2Amax is typically ±0.02–0.07 G. The relative values of 2ΔAmax were
obtained by calculating the difference of outer hyperﬁne splitting con-
stant for the spectra with or without HNP-1. To assess the rotational
mobility of 12-PCSL, the apparent rotational correlation time (τ) was
determined according to [13]:
τ ¼ 0:65·10−9
 
ΔH0 A0=A−1ð Þ1=2−1
h i
ð1Þ
where ΔH0 is the peak-to-peak width of the center line in gauss, A0 is
the amplitude of the center line, and A−1 is the amplitude of the high
ﬁeld line (see Fig. 2). The rotational correlation time is inversely related
to the motional spin label rate such that an increase in τ indicates
slower motion.
2.4. Fluorescence and thermodynamic measurements
Peptide–lipid interactions were studied by monitoring the change
in the Trp-26 ﬂuorescence emission spectra in the presence of LUVs.
Samples prepared for ﬂuorescence measurements contained 0.02 mM
peptide and a variable phospholipids concentration ranging from 0.1
to 7 mM. Fluorescence measurements were performed on a Jasco
FB-6500 spectrometer. The excitation wavelength was 280 nm, and
emission spectra were recorded between 290 and 400 nm, with a
1 nm slit widths at room temperature [31,32]. A very small emission
band in the range of 290–310 nmdue to tyrosine residues contribution
is present in some samples, but it does not inﬂuence the tryptophan
ﬂuorescence band [33].
Binding experiments of peptide to LUVs (0.02 mMHNP-1 in 50 mM
MOPS buffer at pH 6.8) were performed with an ultraﬁltration assay to
separate lipid phase from the free peptide using Centricon-30 kDa
cut-off ﬁlters (Millipore Inc.). The peptide was added to LUVs at a
peptide:lipid molar ratio of 1:350, 1:250, 1:100, 1:50, 1:30, , 1:20,
1:15, 1:10, 1:5, incubated for 30 min and then centrifuged at 6000×g
for 1 h [36].
The free peptide concentration in the eluate has been determined
through a calibration curve plotting known peptide concentration
versus ﬂuorescence intensity. The amount of the peptide bound to
lipid was measured by subtracting the free peptide concentration
from the total peptide concentration. Based on our CD studies, we
found that α-defensin can form aggregates in solution at physiologi-
cal pH at a concentration above 0.04 mM (data not shown). In all
partition coefﬁcient experiments, HNP-1 concentration has been
maintained below 0.04 mM to avoid peptide aggregation process
that could bring to a misleading determination of free protein
concentration.
The mole fraction partition coefﬁcient (Kp) was determined as
following:
Kp ¼ P½ bilayer= L½ 
 
= P½ wat= W½ 
  ð2Þ
where [P] is the peptide concentration in the bilayer or water phase,
[L] is the molar lipid concentration and [W] is the water molar concen-
tration (55.3 M at 25 °C). The free energies of transfer, ΔG°, fromwater
to lipid were calculated from:
ΔG∘ ¼ −RT lnKp ð3Þ
where R is the gas constant and T is the temperature [34–36].
For quenching experiments, samples were prepared dissolving
HNP-1 in 50 mMMOPS (pH=6.8) at a ﬁnal concentration of 0.02 mM.
Vesicles were added in speciﬁc peptide:lipid molar ratio equal to 1:5,
Fig. 2. Trp emission spectra (range 290–400 nm) of HNP-1 in 50 mM MOPS buffer
(dotted line) and in the presence of LUVs at peptide:lipid molar ratios of 1:250,1:20
and 1:5. The excitation wavelength was 280 nm. The spectra were recorded at room
temperature. Experiments repeated three times gave similar results.
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iodide (KI) was added and ﬂuorescence spectra were recorded.
For doxyl-PCSL quenching experiments, spin labeled LUVs were
prepared with the same protocol of the EPR spectroscopic analysis.
n-PCSL-LUVs were added to a solution containing 0.02 mM HNP-1
in 50 mM MOPS (pH=6.8) to give 1:250, 1:20 and 1:5 peptide:
lipid molar ratios, respectively. Each sample was incubated at room
temperature for almost 30 min and ﬂuorescence emission spectra
were recorded before and after the incubation time as described
[37,38]. For both analysis, quenching effect was calculated as the ratio
between the intensity of ﬂuorescence spectra in the presence and in
the absence of the quencher (i.e. KI or doxyl-PCSL) for each speciﬁc
peptide:lipid ratio. Fluorescence spectra were recorded with Jasco
FB-6500 spectrometer using the same setting as previously described.
3. Results
3.1. Circular dichroism spectroscopy
Conformational changes of HNP-1were investigated byCD spectros-
copy in solution and in the presence of model membranes (Fig. 1). The
native HNP-1 (Fig. 1 open circles) shows a negative band at ~205 nm
and a cross over around 200 nm. The observed bands represent protein
containing β-hairpin secondary structure and some low percentages of
α-helical contribution (12%) [39,40].
For low peptide:lipid molar ratio (1:250), the CD spectrum shows
again the classical absorbance around 205 nm due to the β-hairpin
(Fig. 1 solid squares). Increasing peptide concentrations (1:20 and 1:5),
a change in terms of molar ellipticity and shape of the absorbance
band has been observed (Fig. 1 closed circles and triangles respectively).
CD spectrum for the 1:20 ratio (Fig. 1 solid triangles) shows positive
band at 198 nmand negative band at 215 nmwith aβ-sheet lineshape.
For 1:5 ratio (Fig. 1 solid circles), the spectrum is characterized by a
singleminimumat ~215 nm typical of aβ-sheet structure but no cross-
over is revealed. Probably high peptide concentration could determine
peptide–lipid aggregation causing spectral distortion.
3.2. Emission ﬂuorescence spectroscopy
Changes in Trp ﬂuorescence have been used as a probe to monitor
variations in the local hydrophobic environment of a protein or peptide.
In this context HNP-1 contains a single tryptophan residue (Trp-26).
Fig. 2 displays the tryptophan emission spectra of HNP-1 in solutionFig. 1. Circular dichroism spectra (190–250 nm range) of HNP-1 in 50 mMMOPS buffer
(open circles) and in the presence of LUVs at peptide:lipid molar ratio 1:250 (squares),
1:20 (triangles) and 1:5 (solid circles). Baselines of either solvent or vesicular suspension
without peptide have been subtracted from each sample. Spectral distortion is present
below 195 nm. Data are representative of three independent experiments.and in the presence of different amounts of negatively charged lipo-
somes. A blue shift and a variation in quantumyield are typical features
of when a Trp residue moves from water to an apolar environment
[32]. The maximum emission of HNP-1 at 343 nm (Fig. 2 dotted line),
is typical of a peptide containing an indole moiety. Adding a large
amount of lipid phase to reach 1:250 peptide:lipid ratio a decrease in
ﬂuorescence quantum yield accompanied by blue shift of the emission
band is evident (Fig. 2). The change in quantum yield is in the opposite
direction from lower (1:250) to higher (1:20) peptide:lipid molar
ratios (Fig. 2) indicating a different mechanism of interaction. The
blue shift of the band and the enhancement of the ﬂuorescence quan-
tum yield for 1:20 ratio indicates that the tryptophan is located in an
apolar space [31,32]. Interestingly, when reached 1:5 peptide:lipid
molar ratio the blue shift ismaintainedwhile the ﬂuorescence intensity
of Trp-26 returns at the same intensity of that of the free peptide in
solution. This trend suggests a different partitioning mechanism of
HNP-1 with the lipid bilayer.
3.3. Electron Paramagnetic Resonance measurements
The EPR technique has been proved to be a powerful tool tomonitor
the peptide–membrane interaction using site-speciﬁc spin-labeled
lipids [13,41–44].
To assess the effects of the HNP-1 interactionwith lipidmembranes,
themotion of phosphatidylcholine spin labelswith the nitroxidemoiety
positioned at various depths along the alkyl chain has been examined.
CW-EPR spectra for 5-, 7- and 12-PCSL in POPE:POPG:CL (70:25:5)
LUVs with and without HNP-1 are shown in Fig. 3. The increase in
2Amax reﬂects the selectivity of the interaction with lipid head-groups
and also the different strengths of lipid interaction with the peptide.
Fig. 4 shows the increase of 2ΔAmax for 5- (squares) and 7-PCSL
(circles) rising peptide:lipid molar ratio. The most pronounced pat-
terns of selectivity and the largest degrees of perturbation (i.e., largest
values of 2ΔAmax) are obtained adding 1:5 and 1:10 HNP-1 to LUV
membranes (2ΔAmax=2.54±0.07 G and 2ΔAmax=2.75±0.07 G,
respectively), while for the other ratios a strong decrease of about
80% is observed for 5-PCSL. A similar trend is observed for 7-PCSL,
although changes are smaller than for 5-PCSL. Table 1 gives the values
of 2ΔAmaxrecorded for various peptide:lipid molar ratios for 5- and
7-PCSL.
Since 12-PCSL undergoes more rapid motion than 5- or 7-PCSL,
the outer splitting constant (2Amax) is less sensitive to changes in
mobility than the width of the center line (ΔH0) or relative line
amplitudes, which can be used to calculate an empirical rotational
Fig. 3. EPR spectra of 5-PCSL (A), 7-PCSL (B) and 12-PCSL (C) positional isomers of spin
-labeled phosphatidylcholine in ﬂuid-phase LUVs, with (upper spectrum) and without
(lower spectrum) HNP-1 for 1:20 peptide:lipid molar ratio. The increase in 2Amax
observed for 5- and 7-PCSL indicates a decrease in rotational mobility. For 12PCSL the
rotational correlation time is inversely related to themotional spin label rate. Scanwidths
are 120 G, modulation amplitude 1.0 G. Shown is a typical experiment out of three.
Table 1
Differences in outer hyperﬁne splittings (2ΔAmax) of phospholipid probes, for 5-PCSL
and 7-PCSL, incorporated in LUVs at different peptide:lipid molar ratios.
Pep:lip molar ratio 5-PCSL 7-PCSL
2ΔAmax±0.07 G 2ΔAmax±0.06 G
1:30 0.30 0.19
1:20 0.49 0.09
1:15 0.29 0.19
1:10 2.75 1.19
1:5 2.54 0.97
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12-PCSL, variation in peptide concentration does not produce signiﬁ-
cant changes in ΔH0 and rotational correlation time (τ) except for the
1:20 peptide:lipid molar ratio (Table 2).3.4. Partition coefﬁcient measurements
Fluorescence measurements can also be conveniently used to cal-
culate the partitioning equilibrium of the peptide into LUVs. Partition
coefﬁcient (Kp) and insertion free energy of various peptide:lipid molar
ratios were determined as described in the Material and methods sec-
tion and data are summarized in Table 3. As shown in Fig. 5, the increase
in Kp has been recorded accordingly to the amount of added liposomes.
For low peptide:lipid molar ratio (from 1:350 to 1:100), the lowest
values of the partition coefﬁcient indicate a weak interaction of peptideFig. 4. Difference in the outer hyperﬁne splittings (2ΔAmax) of n-PCSL, 5-PCSL (squares)
and 7-PCSL (circles) for different HNP-1:LUV ratios. Error bars indicate standard devi-
ations from three different measurements.with the lipid phase. For 1:15 and 1:20 peptide:lipid molar ratios, there
is a strong increase of Kp values. For 1:20 peptide:lipid molar ratio,
HNP-1 is prevalently associatedwith the phospholipid bilayer. The rel-
ative partition coefﬁcient is higher than all the other ratios and it is re-
lated to a lower value of free energy. The mole-fraction partition
coefﬁcient for 1:5 HNP-1:LUVs ratio is 0.37×103±5%. This yields a
water-to-bilayer free energy transfer of ΔG°=−3.51±0.3 kcal/mol
while for the 1:20 molar ratio a value of Kp=0.68×103±5% and
ΔG°=−3.85±0.3 kcal/mol have been determined. These results
show a strong interaction with the bilayer for the 1:20 peptide:lipid
molar ratio while for the other ratios weaker interactions can be
revealed.3.5. Tryptophan quenching experiments
Potassium iodide (KI) can be used to determine the water expo-
sure of tryptophan residues. If the residue is solvent exposed, iodide
quenches its ﬂuorescence emission. In Table 4 the values of KI
quenching expressed as ratio between the ﬂuorescence intensity in
the presence and in the absence of the quencher for three speciﬁc
peptide:lipid molar ratios are reported. The maximum KI quenching
is found for 1:250 ratio, suggesting that HNP-1 is largely exposed to
buffer. For the other two ratios, the Trp-26 is more localized into
the bilayer.
To determine the depth of HNP-1 penetration into LUVs,
doxyl-quenching experiments have been performed using the same
spin-labeled membranes adopted in the EPR experiments. The doxyl
radical anchored at different positions of the phospholipid tails
(i.e. 5, 7 and 12 carbon of PC lipid) can quench the Trp-26 ﬂuores-
cence when peptide approaches the lipid bilayer. For low peptide:
lipid molar ratio (1:250) only the doxyl linked to 5 carbon of PC
lipid quenches the Trp-26 ﬂuorescence, indicating a superﬁcial pep-
tide interaction. The well pronounced quenching that occurs at 1:20
peptide:lipid ratio is consistent with peptide penetration into the
middle hydrocarbon space of lipid bilayer. On the other hand, for
the highest peptide:lipid molar ratio tested (1:5) the maximum
value of doxyl-quenching is relative to 5- and 7-PCSL indicating that
HNP-1 is inserted into vesicles but interacts prevalently with the
outer part of membrane (Table 4).Table 2
Motional parameters for 12-PCSL incorporated in LUVs as a function of peptide:lipid
molar ratio.
Pep:lip molar ratio ΔH0±0.02 G a τ±0.07 nsb
0:1 2.76 2.31
1:30 2.77 2.36
1:20 2.86 2.44
1:15 2.76 2.38
1:10 2.73 2.28
1:5 2.71 2.31
Mean±standard error of the apeak–peak width of the center line (ΔH0) and rotational
bcorrelation time (τ) are from three different experiments.
Table 3
a Partition coefﬁcients and b free energies of HNP-1 into LUVs determined at various
peptide:lipid molar ratios. The wavelength range of 330–340 nm has been used to cal-
culate the amount of free peptide in solution.
Pep:lip molar ratio Kp∙10−3±5%a ΔG°±0.3 kcal/mol b
1:350 0.07 −2.44
1:250 0.02 −1.87
1:100 0.04 −2.12
1:50 0.11 −2.76
1:30 0.34 −3.40
1:20 0.68 −3.85
1:15 0.62 −3.78
1:10 0.35 −3.46
1:5 0.37 −3.51
Table 4
Measurements of Trp ﬂuorescence quenching to determine penetration depth of
peptide into lipid bilayer and water exposed indole moiety.
Pep:lip molar ratio KIa 5-PCSLb 7-PCSLb 12-PCSLb
1:250 0.33 0.61 0.95 0.96
1:20 0.75 0.52 0.61 0.41
1:5 0.59 0.29 0.25 0.83
Fluorescence maximum intensity is recorded in 330–340 nm range. Quenching is
calculated as ratio between the ﬂuorescence intensity in the presence and in the
absence of quencher for each peptide:lipid molar ratio.
a KI quencher is used to determine water exposed Trp residue with LUVs in solution.
b The doxyl-labeled lipid quenches Trp ﬂuorescence in a distance dependent manner
giving the depth of peptide penetration into vesicles.
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It is well known that cationic and hydrophobic residues of pep-
tides and lipid composition of membranes are the factors that mainly
affect the activity of AMPs [1–7]. HNP-1 has a positive net charge
equal to +3, conferred by four cationic arginine residues and a single
anionic glutamic acid residue [17,18,21]. The cationic nature of defensins
suggests that their antimicrobial activity prevalently depends upon elec-
trostatic interactions [19,20].
Large unilamellar vesicles (LUVs) resembling the composition of
the Escherichia coli inner membrane have been used in this work.
These vesicles have a more complex structure compared to simpler
model membranes commonly used in other works and cardiolipin
confers a negative charge and a rigid structure to the vesicle surface.
[12,37,45,46]. The relative peptide:lipid molar ratio is another impor-
tant aspect to evaluate the antimicrobial activity of a peptide. High
concentrations of bound peptide are required for antimicrobial activity
but AMPs that present activity and leakage only at a peptide:lipidmolar
ratio higher than 1:50 can be considered as experimental artefacts [45].
In the vast literature on pore-forming peptides, convincing evi-
dences for speciﬁc three dimensional transmembrane pore structures
is rare. Recently, a solid state NMR study has been performed to elu-
cidate the three dimensional structure of the pores formed by the
human HNP-1 peptide in DMPC:DMPG bilayer using a 1:18 peptide:
lipid molar ratio [12]. This peptide concentration is far away from
the ones of the biological activity.
In this work, the binding properties of HNP-1 with negative
charged lipid phase has been examined with the aim to shed light on
the overall mechanism of HNP-1-membrane interaction at different
concentrations of peptide.Fig. 5. Partition coefﬁcients calculated for (1:350, 1:250, 1:100 and 1:50) and (1:30,
1:20, 1:15, 1:10 and 1:5) peptide:lipid molar ratios.HNP-1 in its native form has a compact structure composed of
three antiparallel β-sheet and a β-hairpin interconnected by three
disulﬁde bonds. Furthermore, the crystal structure, as well as equilib-
rium sedimentation studies, suggests that defensins exist as dimers
or higher multimers in solution [19,25]. The CD spectra of native
defensins exhibit changes in the presence of increasing amount of
lipids suggesting that a reorganization process takes place during
phospholipid destabilization (Fig. 1). Indeed, a basket shape dimer
with a polar top and an apolar base was resolved by crystal structure
studies and proposed to translocate to membrane environment
maintaining its dimeric structure [25]. The same behavior was also
evidenced for other AMPs in previous studies [37,46].
The emission ﬂuorescence spectra have given more interesting
results. HNP-1 in solution reveals the maximum emission band at
343 nm, typical of a solvent exposed Trp. For 1:250 peptide:lipid
molar ratio a decrease of ﬂuorescence quantum yield paired with a
shift of the emission band (332 nm) is recorded. In this condition
Trp-26 is conﬁned to the outer leaﬂet of the membrane and the pep-
tide is partially associated to lipid bilayer.
Once the 1:20 HNP-1:LUVs ratio is reached, a large amount of
defensin penetrates into the lipid bilayer as indicated by the blue shift
(332 nm) of the emission band and the strong increase in quantum
yield. In this condition, Trp is displaced to the apolar environment of
the lipid phase. The samevalue of the Trpﬂuorescencewas theoretically
predicted by us for the residue in the apolar environment of a protein
[47]. For high peptide:lipid molar ratio (1:5) the blue shift at 332 nm
suggests an interfacial location of the Trp residue. These results are in
perfect agreement with the EPR and quenching experiments. The EPR
spectroscopy, in fact, is a powerful tool to evaluate the interaction and
insertion of AMPs into pospholipid bilayer. The analysis of the changes
in outer splitting constant of a spin-label nitroxyl radical anchored
in a different position of the lipid bilayer allowed us to understand
the ability of the peptide to penetrate into membranes. Our EPR data
show that for 1:250 ratio no destabilization of the inner part of mem-
brane is present, but only a weak interaction with 5-PCSL (data not
shown) evidencing a poor binding with the membrane surface. On
the other hand, an increase of the correlation time in the case of
12-PCSL has been recorded only for 1:20 peptide:lipid ratio. For high
peptide:lipid molar ratio (1:5 and 1:10) HNP-1 interacts prevalently
with 5-PCSL and in a lesser extent with 7-PCSL (Fig. 4 and Table 1).
No variation for interaction with the 12-PCSL has been recorded for
these two ratios (see correlation time, Table 2), emphasizing that the
interaction is prevalently localized on the outer part of the bilayer,
thus leading to phospholipid destabilization. From our EPR data we
cannot clearly deﬁne the correct mechanism of pore formation at the
threshold concentration (1:20), but the change in correlation time
of 12-PCSL shows that the peptide penetrates into the bilayer in a
membrane spanning-mode.
The partition coefﬁcient and relative free energy values are well
in agreement with the other data. The higher value for partition coef-
ﬁcient paired with the lower value for free energy has been recorded
at the 1:20 molar ratio (Table 3). The experiments in the presence of
763A. Bonucci et al. / Biochimica et Biophysica Acta 1828 (2013) 758–764the water soluble quencher KI show that the peptide at low concen-
tration (1:250) is placed on the surface with the Trp residue more
exposed to solvent than at higher peptide concentration (1:5). At the
threshold concentration (1:20) Trp is inserted into the lipid bilayer.
The experiments with doxyl labeled-lipids show clearly that the inter-
action with 12-PCSL is exerted only at the peptide threshold condition.
Considering this we can speculate that Trp, originally parallel oriented
to membrane surface, penetrates into the bilayer changing its orien-
tation in a manner with the indole moiety less exposed to water solu-
tion. At higher peptide concentrations (high peptide:lipid molar ratio)
the α-defensin resides mainly on the bilayer surface, even if deeper
inserted than for lower ratios, and the more suitable mechanism of
action can be based on the non-speciﬁc “interfacial activity” leading to
membrane-destabilizing effect altering the packing and organization
of the lipids. [46,48,49].
5. Conclusion
Overall, this work provides further insights into the bindingmode of
the human α-defensin HNP-1 with negative phosholipid bilayer indi-
cating that themode of interaction is peptide concentration dependent.
For lower ratios (1:250–1:350), the most “physiological” concen-
trations, the activity is prevalently localized on membrane surface.
This can bring to a thinning and destabilization of phospholipid bilayer.
Increasing peptide concentration at 1:20 ratio the penetration and pore
formation is the more suitable mechanism of action. This ratio repre-
sents the threshold concentration for the trans-membrane spanning
mode. Strongmembrane destabilization and partitioning of the peptide
in the phospholipid bilayer is from the other hand presents for high
peptide:lipid ratios (1:10–1:5).
This work can be useful to understand the mode of action of
HNP-1 but at the same time can be considered as a model to demon-
strate how the change in peptide concentration and the presence of a
lipid membrane highly negatively charged can be crucial to deﬁne the
biological activity for AMPs.
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